Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Other Operating Expenses (2022 - 2025)

Historic Other Operating Expenses for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $1.2 million.

  • bioAffinity Technologies' Other Operating Expenses fell 2981.76% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year decrease of 1351.36%. This contributed to the annual value of $6.7 million for FY2024, which is 23506.41% up from last year.
  • Per bioAffinity Technologies' latest filing, its Other Operating Expenses stood at $1.2 million for Q3 2025, which was down 2981.76% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Other Operating Expenses registered a high of $1.8 million during Q4 2024, and its lowest value of -$16999.0 during Q4 2022.
  • In the last 4 years, bioAffinity Technologies' Other Operating Expenses had a median value of $1.2 million in 2025 and averaged $856808.7.
  • The largest annual percentage gain for bioAffinity Technologies' Other Operating Expenses in the last 5 years was 1035185.6% (2023), contrasted with its biggest fall of 6245.17% (2023).
  • bioAffinity Technologies' Other Operating Expenses (Quarter) stood at -$16999.0 in 2022, then skyrocketed by 10351.86% to $1.7 million in 2023, then grew by 3.32% to $1.8 million in 2024, then crashed by 35.89% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, $1.2 million for Q2 2025, and $1.6 million during Q1 2025.